Claudia from the US shares her experience of MCAS and POTS symptoms, how long it took her to be diagnosed and the treatments she's having.

Rebecca Mass-Krajewski, NP, talks about how LDN can help patients with the trifecta of HEDS, POTS, and MCAS, along with the percentiles of improvement she sees in her clients.

Miriam Martinez Callejas is the Superintendent Pharmacist and co-founder of Roseway Labs. During her master’s degree in Pharmacy, she trained in formulating medication and her first job was in a compounding pharmacy in Spain. There, she developed a passion for helping others using her experience and knowledge of medicine. At Roseway Labs, both prescribers and patients benefit from the formulations and compounding expertise that Miriam has developed over the past 20 years. She develops new...

Samantha Lebsock, PharmD, received her Bachelor's in Human Biology and Doctor of Pharmacy from the University of Montana. She began working at Belmar Pharmacy in 2014. She is the Director of Product Development and Clinical Research for Belmar Pharma Solutions and the resident LDN specialist. Samantha has become an expert in compounded medication formulations and has become a trusted advisor to providers around the country. For information on LDN, go to https://linktr.ee/ldnrt Our webinars...

Steve Irsfeld is the owner of Irsfeld Pharmacy PC in Dickinson. Steve graduated from NDSU College of Pharmacy in 1988. After working in Fargo as an intern and staff pharmacist he returned to Dickinson to work alongside his dad and has been there for the last 28 years. Pharmacy is a family affair for Steve; NDSU School of Pharmacy has graduated his father, Jim, his daughter, Molly , and 3 uncles (one misguided cousin graduated from some other school) Irsfeld Pharmacy has been a Professional...

Ioana Vintila is a national board-certified health coach and founder of the POTS Possibilitation Program. She specializes in helping individuals with POTS and dysautonomia minimize their symptoms and uncover what's possible for them on their healing journey. Her holistic approach is based on coaching individuals around energy management, nervous system regulation, nutrition, and physical activity. Ioana guides individuals to implement this formula, offering hope and step-by-step guidance to...

Dr Sajad Zalzala from the US talks about the LDN and Anti-Aging Survey. He is the principal investigator.

Belita from the USA is a retired MD, she shares her amazing LDN Story for Chronic Pain.

Jill Brook from the US is a Researcher, Nutritionist and POTS patient and advocate who shares her experience with us.

Lupus is a complicated epigenetic process of cellular interactions that happen in genetically-susceptible people who are exposed to random and unknown environmental factors that create the conditions of lupus, or auto other autoimmune diseases. She discusses four mechanisms of action in regards to lupus and the cellular abnormalities, and recommended treatments. LDN has a positive impact, decreasing the risk of epigenetic changes as it decreases the oxidative damage. It adjusts the...

Lichen planopilaris is an autoimmune-mediated disorder with scarring hair loss. Dr. Bodemer identifies the clinical signs of lichen planopilaris (LPP), describes the autoimmune pathogenesis of lichen planopilaris, talks about the three main variants, lists some of the lifestyle factors and supplements that may be helpful in treating this condition, and helps to understand the role low dose naltrexone (LDN) may play in treating LPP. As an autoimmune disease, there is increased risk of other...

Sita from the US is a Nutritionist, POTS and EDS patient who shares her health journey with us

Compounding Pharmacist Dr Erin Panian shares her LDN experience.

Treating depression in patients with autoimmune conditions a presentations for the LDN 2019 conference by Beth Livengood NMD

Pamela Smith, MD presented LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis at the LDN Research Trust 2019 Conference

Jill Brook, MA - Intermittent Fasting presentation at the LDN Research Trust 2019 Conference

Traumatic Brain Injury Presentation by Dr Sarah Zielsdorf at the LDN Research Trust Conference

Wiebke Pape MD Presents Dissociative Symptoms in Trauma-Related Disorders at the LDN Conference

Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)

Nutritionist Jill Brook from the US discusses LDN as a treatment for POTS and MCAS on the LDN Radio Show.

Dr. Weinstock discussed his plans for a documentary about MCAS, POTS, and ED, three conditions that are often misunderstood and difficult to manage. He hopes that by sharing the stories of patients and experts in the field, he can help educate the public and healthcare providers about these conditions. Dr. Weinstock also emphasized the importance of working closely with healthcare providers to find the right treatment plan for each individual patient. While LDN may be a helpful tool for some,...

Dr Tania Dempsey talks about hard to diagnose conditions, including MCAS, POTS, EDS etc

Pharmacist Ray Solano from PD Labs shares his experience of Low Dose Naltrexone (LDN)

Madi Wend, Mental Health Therapist, and chronic diseases, shares her experience